Magnetic resonance laparoscopy: A new non-invasive technique for the assessment of chronic viral liver disease

Hepatology Research

Volumn 43, Issue 8, 2013, Pages 836-845

  Ogura, Suguru ^a   Saitoh, Satoshi ^a   Kawamura, Yusuke ^a   Sezaki, Hitomi ^a   Hosaka, Tetsuya ^a   Akuta, Norio ^a   Kobayashi, Masahiro ^a   Suzuki, Fumitaka ^a   Suzuki, Yoshiyuki ^a   Arase, Yasuji ^a   Ikeda, Kenji ^a   Kumada, Hiromitsu ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

Chronic hepatitis; Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid; Laparoscopy; Multiple resonance imaging; Multiple resonance laparoscopy

Indexed keywords

GADOXETIC ACID;

ADULT; AGED; ARTICLE; CHILD PUGH SCORE; CLINICAL ASSESSMENT; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MAGNETIC RESONANCE LAPAROSCOPY; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VIRUS TYPING;

EID: 84882582258     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12025     Document Type: Article

References (39)

1. Kiyosawa K, Fukura S. Review of hepatitis C in Japan. J Gastroenterol Hepatol 1991; 6: 383-391.
2. Alter MJ, Margolis HS, Kwaczynski K etal. The natural history of community acquired hepatitis C in the United States. N Engl J Med 1992; 327: 1889-1905.
3. Liaw YF, Chu CH. Hepatitis B virus infection. Lancet 2009; 373 (9663): 582-592.
4. Ikeda K, Saitoh S, Suzuki Y etal. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. J Hepatol 1998; 28: 930-938.
5. Hasan F, Jeffers LJ, De Medina M etal. Hepatitis C-associated hepatocellular carcinoma. Hepatology 1990; 12 (3 Pt 1): 589-591.
6. Tsukuma H, Hiyama T, Tanaka S etal. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993; 328: 1797-1801.
7. Ikeda K, Saitoh S, Koida I etal. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospectice observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993; 18: 47-53.
8. Boyce HW. Diagnostic laparoscopy in liver and biliary disease. Endoscopy 1992; 24: 676-681.
9. Nord HJ. Complication of laparoscopy. Endoscopy 1992; 24: 693-700.
10. Poniachik J, Bernstein DE, Reddy KR etal. The role of laparoscopy in the diagnosis of cirrhosis. Gastrointest Endosc 1996; 43: 568-571.
11. Cardi M, Muttillo IA, Amadori L etal. Superiority of laparoscopy compared to ultrasonography in diagnosis of widespread liver diseases. Dig Dis Sci 1997; 42: 546-548.
12. Wietzke-Braun P, Braun F, Schott P, Ramadori G. Is laparoscopy an advantage in the diagnosis of cirrhosis in chronic hepatitis C virus infection? World J Gastroenterol 2003; 9: 745-750.
13. Gainai S, Gramantieri L, Venturoli N etal. What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy. J Hepatol 1997; 27: 979-985.
14. Helmreich-Becker I, Meyer zum Buschenfelde KH, Lohse AW. Safety and feasibility of a new minimally invasive diagnostic laparoscopy technique. Endoscopy 1998; 30: 756-762.
15. Piccinino F, Sagenelli E, Pasquale G, Giusti G. complications following percutaneous liver biopsy. A multicentre retrospective study on 68, 276 biopsies. J Hepatol 1986; 2: 165-173.
16. Montalto G, Soresi M, Carrocio A etal. Percutaneous liver biopsy: a safe outpatient procedure? Digestion 2001; 63: 55-60.
17. Regev A, Berho M, Jeffes LJ etal. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 2614-2618.
18. Bedossa P, Poynaud T; The Metavir Cooperative Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994; 20 (1 Pt 1): 15-20.
19. Westin J, Lagging LM, Wejstal R, Norkans G, Dhillon AP. Interobserver study of liver histology using the Ishak score in patients with chronic hepatitis C virus infection. Liver 1999; 19: 183-187.
20. Williams AL, Hoofnagle JH. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis: relationship to cirrhosis. Gastroenterology 1988; 95: 734-739.
21. Wai CT, Greenson JK, Fontana RJ etal. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 518-526.
22. Sterling RK, Lissen E, Clumeck N etal. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006; 43: 1317-1325.
23. Ikeda K, Saitoh S, Kobayashi M etal. Distinction between chronic hepatitis and liver cirrhosis in patients with hepatitis C virus infection. Practical discriminant function using common laboratory data. Hepatol Res 2000; 18: 252-266.
24. Sandrin L, Fourquet B, Hasquenoph JM etal. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29: 1705-1713.
25. Ziol M, Handra-Luca A, Kettaneh A etal. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41: 48-54.
26. Castéra L, Vergniol J, Foucher J etal. Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128: 343-350.
27. Tanimoto A, Yuasa Y, Shinmoto H etal. Superparamagnetic iron oxide-mediated hepatic signal intensity change in patients with and without cirrhosis: pulse sequence effects and Kupffer cell function. Radiology 2002; 222: 661-666.
28. Sandrasegaran K, Akisik FM, Lin C etal. Value of diffusion -weighted MRI for assessing liver fibrosis and cirrhosis. AJR Am J Roentgenol 2009; 193: 1556-1560.
29. Boulanger Y, Amara M, Lepanto L etal. Diffusion-weighted MR imaging of the liver of hepatitis C patients. NMR Biomed 2003; 16: 132-136.
30. 31P MRS study of patients with liver cirrhosis: progress towards a non-invasive assessment of disease severity. NMR Biomed 1993; 6: 168-172.
31. Rouvière O, Yin M, Dresner MA etal. MR elastography of the liver: preliminary results. Radiology 2006; 240: 440-448.
32. Arase Y, Suzuki F, Suzuki Y etal. Potential of laparoscopy in chronic liver disease with hepatitis B and C viruses. Hepatol Res 2008; 38: 877-885.
33. Shiraki K, Shimizu A, Takase K etal. Prospective study of laparoscopic findings with regard to the development of the hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis. Gastrointest Endosc 2001; 53: 449-455.
34. Saito K, Kotake F, Ito N etal. Gd-EOB-DTPA enhanced MR imaging for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase. Magn Reson Med Sci 2005; 4: 1-9.
35. Kogita S, Imai Y, Okada M etal. Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow. Eur Radiol 2010; 20: 2405-2413.
36. Orlando R, Lirussi F, Okolicsanyi L. Laparoscopy and liver biopsy: further evidence that the two procedures improve the diagnosis of liver cirrhosis. A retrospective study of 1, 003 consecutive examinations. J Clin Gastroenterol 1990; 12: 47-52.
37. Bluemke DA, Sahani D, Amendola M etal. Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study. Radiology 2005; 237: 89-98.
38. Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999; 19: 329-338.
39. Fujioka S, Yamamoto K, Okamoto R etal. Laparoscopic features of primary biliary cirrhosis in AMA-positive and AMA-negative patients. Endoscopy 2002; 34: 318-321.